Pentagon Details Annual Testosterone Screening Policy And Voluntary Hormone Therapy For Troops Over 30
On Wednesday, July 15, 2026, Defense Secretary Pete Hegseth announced in a video that the Pentagon will institute annual "testosterone deficiency" screening for service members age 30 and older and offer voluntary testosterone replacement therapy.[1]
Hegseth said service members younger than 30 could request testing, and he framed the initiative as helping troops operate at their "absolute best." PBS In his social media video he referred generally to "troops" but appeared to be talking mainly about men, and the Pentagon did not answer whether women will be eligible for analogous estrogen-based evaluations.[1] When asked about the evidence base, the Pentagon did not identify specific research and instead cited Hegseth's remarks about strength, resilience, and psychological and mental readiness.[1]
A 2022 Navy SEAL recruit death that uncovered testosterone and other substances led the Navy in 2023 to begin drug-testing SEAL candidates for hormonal substances tied to muscle growth, a backdrop Hegseth said his plan is "not about artificial enhancement." PBS The move also fits a broader administration push to ease men's access to testosterone, including steps by Health Secretary Robert F. Kennedy Jr. and a recent FDA proposal to loosen prescribing limits beyond current hypogonadism-only labeling.[1]
CBS News likewise reported Hegseth's requirement for testosterone deficiency screening for service members over 30.[2]
Show source details & analysis (2 sources)
📌 Key Facts
- On Wednesday, July 15, 2026, Defense Secretary Pete Hegseth framed the new program in a video as annual “testosterone deficiency” screening for troops age 30 and older so they can operate at their “absolute best.”
- Testosterone replacement therapy under the program will be voluntary, and Hegseth said service members under 30 will be able to request testing.
- In his social media video Hegseth referred generally to “troops” but appeared to be talking only about men, and the Pentagon did not answer whether women will be eligible for analogous estrogen-based evaluations as they enter perimenopause.
- When asked about the evidence base, Hegseth's general remarks about strength, resilience and psychological and mental readiness were cited; the Pentagon did not identify specific research or academic studies underpinning the screening rollout.
- The policy is presented as part of a broader administration push: Health Secretary Robert F. Kennedy Jr. and others are moving to make it easier for men to obtain testosterone therapy, and the FDA last month proposed easing prescribing limits on testosterone drugs beyond current hypogonadism-only labeling.
- Background: a 2022 Navy SEAL recruit death led to discovery of testosterone and other substances and prompted a 2023 Navy decision to drug-test SEAL candidates for hormonal substances tied to muscle growth; Hegseth said his initiative is “not about artificial enhancement.”
📰 Source Timeline (2)
Follow how coverage of this story developed over time
- On Wednesday, July 15, 2026, Defense Secretary Pete Hegseth publicly framed the new program in a video as annual 'testosterone deficiency' screening for troops age 30 and older so they can operate at their 'absolute best.'
- Hegseth said testosterone replacement therapy under the program will be voluntary and that service members under 30 will be able to request testing.
- The article reports that, in his social media video, Hegseth referred generally to 'troops' but appeared to be talking only about men, and the Pentagon did not answer a PBS question about whether women will be eligible for analogous estrogen-based evaluations as they enter perimenopause.
- The Pentagon did not identify specific research or academic studies underpinning the screening rollout when asked, instead pointing back to Hegseth's general remarks about strength, resilience, and psychological and mental readiness.
- The story connects the policy to a broader Trump administration push, noting that Health Secretary Robert F. Kennedy Jr. and others are moving to make it easier for men to obtain testosterone therapy and that the FDA last month proposed easing prescribing limits on testosterone drugs beyond current hypogonadism-only labeling.
- The article recalls that a 2022 Navy SEAL recruit death led to discovery of testosterone and other substances in his possession and to a Navy decision in 2023 to start drug-testing SEAL candidates for any hormonal substance related to testosterone that promotes muscle growth, a backdrop Hegseth addressed by saying his initiative is 'not about artificial enhancement.'